Estimation of the level of anxiety in rats: Differences in results of open-field test, elevated plus-maze test, and Vogel's conflict test

Bulletin of Experimental Biology and Medicine

Volumn 155, Issue 3, 2013, Pages 295-297

  Sudakov, S K ^a   Nazarova, G A ^a   Alekseeva, E V ^a   Bashkatova, V G ^a  

^a P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

Author keywords

elevated plus maze; individual level of anxiety; motivation; open field; Vogel's conflict test

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; ELEVATED PLUS MAZE TEST; INTERMETHOD COMPARISON; MALE; NONHUMAN; OPEN FIELD TEST; PUNISHMENT; RAT; RELIABILITY; STANDARDIZATION; VOGEL TEST; ANIMAL; CONFLICT; DIAGNOSIS; DIAGNOSTIC TEST; MAZE TEST; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SPATIAL BEHAVIOR; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANXIETY; CONFLICT (PSYCHOLOGY); DIAGNOSTIC TESTS, ROUTINE; MALE; MAZE LEARNING; RATS; RATS, WISTAR; SPATIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 84881179532     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2136-y     Document Type: Article

References (15)

1. V. G. Bashkatova, Psikhofarmakol. Biol. Narkol., 8, No. 1, Pt. 1, 2240-2248 (2008).
2. Z. A. Zorina, I. I. Poletaeva, and Zh. I. Reznikova, Foundations for Aetiology and Genetics of Behavior [in Russian], Moscow (2002).
3. E. V. Koplik, Vestn. Nov. Med. Tekhnol., 9, No. 1, 16-18 (2002).
4. S. S. Pertsov, E. V. Koplik, and L. S. Kalinichenko, Bull. Exp. Biol. Med., 152, No. 1, 1-4 (2011).
5. R. Andreatini and L. F. Bacellar, Prog. Neuropsychopharmacol. Biol. Psychiatry, 24, No. 4, 549-560 (2000).
6. Y. Clèment, A. M. Le Guisquet, P. Venault, et al., PLos One, 4, No. 4, e7745 (2009).
7. D. A. Finn, M. T. Rutledge-Gorman, and J. C. Grabbe, Neurogenetics, 4, No. 3, 109-135 (2003).
8. C. S. Hall, J. Comp. Psychol., 18, No. 3, 385-403 (1934).
9. D. J. Nutt, and D. J. Stein, CNS Spectr., 11, No. 10, Suppl. 12, 13-20 (2006).
10. S. Pellow, P. Chopin, S. E. File, and M. Briley, J. Neurosci. Methods, 14, No. 3, 149-167 (1985).
11. A. Ramos, E. Pereira, G. C. Martins, et al., Behav. Brain Res., 193, No. 2, 277-288 (2008).
12. A. Ramos, Trends Pharmacol. Sci., 29, No. 10, 493-498 (2008).
13. M. B. Ruarte and E. O. Alvarez, Braz. J. Med. Biol. Res., 32, No. 1, 99-106 (1999).
14. S. K. Sudakov, O. F. Medvedeva, I. V. Rusakova, et al., Psychopharmacology (Berl), 154, No. 4, 327-335 (2001).
15. W. Vogel, R. W. Baker, and R. S. Lazarus, J. Abnorm. Soc. Psychol., 56, No. 1, 105-112 (1958).